OTC · Financial Statements
Instadose Pharma Corp. (INSD) Financial Statements
$0.00
OTC: INSD
Market Cap $53193
Overview Financials Dividend Instadose Pharma Corp. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 $0 $0 $0 $0 Operating Profit $0 $0 $0 $0 $0 Net Profit $0 $0 $0 $0 $-1.0M EPS $0.00 $0.00 $0.00 $0.00 $0.00 Op Margin — -653.0% — — —
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $0 $0 $0 $0 $0 Total Liabilities $0 $0 $0 $0 $0 Cash $0 $0 $0 $0 $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $0 $0 $0 $0 $0 Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $0 $0 $0 $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.53 FCF Yield -0.16% Quick Ratio 0.00 Interest Coverage 0.00 Return 1Y -90.91% Return 3Y -90.91% Return 5Y —
Screens featuring this stock